Rebecca Li, Ph.D., is the Executive Director of Vivli and Senior Advisor of MRCT Center. Previous to her current role she was the Executive Director of the MRCT Center of Brigham and Women’s Hospital and Harvard for over 5 years and remains a Senior Advisor at the Center. The MRCT Center is a neutral convening organization that works to define actionable policy solutions for the clinical trial enterprise. The Center was chartered to improve the integrity, safety and rigor of global clinical trials. Dr. Li has over 20 years of experience spanning the entire drug development process with experience in Biotech, Pharma and CRO environments. She currently is an Instructor in Medicine in the Division of Global Health Equity, Department of Medicine in the Harvard Medical School and teaches Research Ethics at the Center for Bioethics. She completed a Fellowship in 2013 in the Division of Medical Ethics at Harvard Medical School. Prior to joining Harvard, Dr. Li served as the VP of Clinical Research at the New England Research Institutes for 6 years. She was also previously employed at Wyeth Research as the Associate Director in Translational Clinical Research. She earned her PhD in Chemical and Biomolecular Engineering from Johns Hopkins University..